Nitroglycerin: a NO donor inhibits TPA-mediated tumor promotion in murine skin

P Trikha1, N Sharma, M Athar

  • 1Department of Medical Elementology and Toxicology, Hamdard University, Hamdard Nagar, New Delhi 110 062, India. prashant_trikha@hotmail.com

Carcinogenesis
|July 27, 2001
PubMed

Insights

Nitroglycerin (GTN), a nitric oxide (NO) generator, inhibited tumor promotion in mice. This chemopreventive agent reduced tumor incidence and yield, suggesting NO

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Nitric oxide (NO) plays a complex role in tumor promotion.
  • Nitroglycerin (GTN) is a vasodilator that generates NO.
  • Understanding NO's role in skin tumorigenesis is crucial for chemoprevention.

Purpose of the Study:

  • To investigate the role of NO, generated by GTN, in inhibiting skin tumor promotion in mice.
  • To evaluate GTN's potential as a chemopreventive agent against skin tumorigenesis.

Main Methods:

  • Murine skin tumor models were used, involving 12-O tetradecanoyl phorbol 13-acetate (TPA) and/or DMBA.
  • GTN was administered to TPA-treated mice to assess its effects on biochemical markers and tumor development.
  • Glutathione levels, antioxidant enzyme activity, ornithine decarboxylase (ODC) activity, and DNA synthesis were measured.

Main Results:

  • GTN administration dose-dependently inhibited glutathione levels and antioxidant enzyme activity.
  • GTN significantly reduced ODC activity and [3H]thymidine incorporation into epidermal DNA.
  • In DMBA-initiated, TPA-promoted mice, GTN increased tumor latency, decreased tumor incidence by 32%, and reduced tumor yield by 2-fold.

Conclusions:

  • Nitric oxide (NO) can effectively abrogate the toxic and tumor-promoting effects of TPA in murine skin.
  • Nitroglycerin (GTN) demonstrates significant chemopreventive potential against skin tumorigenesis.
  • GTN's NO-generating properties may offer a novel strategy for inhibiting skin cancer development.

Related Concept Videos